Early, abrupt weaning did not reduce risk of HIV infection or mortality in breast-fed infants of mothers with HIV

P. Millard

DOI: https://doi.org/10.1136/ebm.13.6.182

2008-11-28

Evidence-Based Medicine

Abstract:ED FROM Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 2008;359:130–41. Correspondence to: Dr L Kuhn, Columbia University, New York, NY, USA; lk24@columbia.edu Sources of funding: National Institute of Child Health and Human Development; Centers for Disease Control and Prevention; Agency for International Development; Stephen Lewis Foundation. c Clinical impact ratings: GP/FP/Obstetrics 6/7; Infectious disease 6/7; Paediatrics 6/7; Obstetrics 6/7; Paediatric neonatology 6/7; GP/FP/Primary care 5/7 Early, abrupt weaning v standard weaning by mothers with HIV Infant outcomes at 24 months Early weaning Standard weaning p Value HIV-free survival 68% 64% 0.13 Mortality 24% 25% 0.96 HIV infection 21% 26% 0.11 C O M M EN TA R Y H IV transmission during breast feeding remains a dilemma in areas with high HIV prevalence. Breast feeding is vital to prevent death from diarrhoeal and respiratory diseases in resource-limited settings, and exclusive breast feeding may be safer than combined breast and supplementary feeding. Antiretroviral drugs are effective at preventing HIV acquisition when given during breast feeding, but risk of transmission resumes upon cessation of treatment if breast feeding continues. The study by Kuhn et al illustrates the tragedy of HIV infection in sub-Saharan Africa. Not only did the results show no benefit of abrupt cessation of breast feeding at 4 months, but HIV prevalence in infants was .20% at 2 years (despite mothers being given perinatal nevirapine); overall mortality was a shocking 24%. The study by Kuhn et al was remarkable considering the setting, and complete follow-up was achieved in 84% of infants. Not surprisingly, nearly one-third of women in the intervention group did not follow the protocol, and one-third of women in the standard-care group had stopped breast feeding after 1 year. This would tend to bias the results toward no effect; there was a trend toward lower rates of HIV transmission in the early-weaning group, and so the study may have missed a small benefit of early weaning. Where does this leave those practising in resource-poor areas with high HIV prevalence? Kuhn et al have shown that even exclusive breast feeding is risky, and evidence is mounting that the preferred treatment option will be antiretroviral treatment until infants are at least 14 weeks of age and probably for the duration of breast feeding. Peter S Millard, MD, PhD Universidade Cátolica de Moçambique Beira, Mozambique 1. Coovadia HM, Rollins NC, Bland RM, et al. Mother-tochild transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107–16. 2. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008;359:119–29. Therapeutics 182 EBM December 2008 Vol 13 No 6